Skip to main content
OpenTrials
Completed

NCT Number: NCT05299983

MyMenoPlan: Online Resource for Improving Women's Menopause Knowledge and Informed Decision-making

As part of a National Institute on Aging -funded R01, the investigators developed an evidence-based, multi-media digital resource entitled MyMenoPlan to help women learn about the menopause transition, and the symptoms and treatments of perimenopause/menopause. MyMenoPlan is also designed to help women learn about the effectiveness of treatments for a comprehensive list of midlife symptoms and compare treatments that may help with the specific symptoms women are experiencing.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Menopause Postmenopause Premenopause

Age range

40 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

UC San Diego

La Jolla, California, 92037, United States

About this study

The purpose of this research study is to:

  • Investigate how women randomly assigned to visit MyMenoPlan use the website (time spent on website, treatment and symptom page views, use of interactive tools, and use of the MyMenoPlan tool).
  • Compare the ratings of women randomly assigned to MyMenoPlan to those randomly assigned to other menopause websites for perceived quality of information, readability, self-efficacy, and credibility of these online menopause resources.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • As stated above

Exclusion criteria

  • N/A

Treatment and study plan

MyMenoPlan

Other

Participants are asked to spend at least 20 minutes on the website (MyMenoPlan) assigned to them.

Control

Other

Participants are asked to spend at least 20 minutes on at least one of the following websites:

  • North American Menopause Society: https://www.menopause.org/for-women
  • National Institute on Aging: https://www.nia.nih.gov/health/topics/menopause
  • The Office on Women's Health-Menopause: https://www.womenshealth.gov/menopause

Primary outcomes

  1. Perceived Quality of Information

    Time frame: Each survey question is answered after spending at least 20 minutes on the assigned website(s)

    This 7-item, 5-point Likert scale (1- Strongly disagree to 5 - Strongly agree) is adapted from the Post-Study System Usability Questionnaire (PSSUQ) in Lewis (1995). The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (perceived quality of information).

    Items:

    • Reading the information made me feel in more control of my perimenopause/menopause.
    • The information on the website(s) was helpful to me.
    • I found the information I was looking for.
    • The information answered my questions about perimenopause/menopause.
    • I liked the website (s).
    • I would have liked more in-depth information. (reverse-coded)
    • The website(s) were fairly comprehensive about perimenopause /menopause.

  2. Readability

    Time frame: Each survey question is answered after spending at least 20 minutes on the assigned website(s)

    This 2-item, 5-point Likert (1- Strongly disagree to 5 - Strongly agree)scale was derived from the Standardized User Experience Percentile Rank Questionnaire (SUPR-Q) in Sauro (1995). The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (readability).

    Items:

    • The information I read was clear.
    • The information I read was easy for me to understand.

  3. Self-Efficacy for Managing Menopause Symptoms

    Time frame: Each survey question is answered after spending at least 20 minutes on the assigned website(s)

    This is a newly developed Likert scale (1- Strongly disagree to 5 - Strongly agree) for assessing participants' beliefs in their own abilities in managing menopausal symptoms. The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (self-efficacy).

    Items:

    • If I want to, I am certain I could figure out the treatments or coping strategies that would work best for me.
    • I feel I could treat or cope with my symptoms of perimenopause/menopause if I want to.

  4. Credibility

    Time frame: Each survey question is answered after spending at least 20 minutes on the assigned website(s)

    This 2-item, 5-point Likert (1- Strongly disagree to 5 - Strongly agree) scale was derived from the Standardized User Experience Percentile Rank Questionnaire (SUPR-Q) in Sauro (1995). The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (credibility).

    Items:

    • The information is credible.
    • The information is trustworthy.

Sponsors and collaborators

Lead sponsor

University of California, San Diego

Other

Registry information

Official study title

MsFLASH: Living a Healthy Menopause, Aim 2 Randomized Controlled Trial of MyMenoPlan

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Mar 29, 2022
Registry last updated
Mar 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.